Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amicus Therapeutics (FOLD) Interest & Investment Income: 2009-2024

Historic Interest & Investment Income for Amicus Therapeutics (FOLD) over the last 16 years, with Dec 2024 value amounting to $5.4 million.

  • Amicus Therapeutics' Interest & Investment Income fell 23.31% to $829,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year decrease of 31.12%. This contributed to the annual value of $5.4 million for FY2024, which is 23.61% down from last year.
  • Latest data reveals that Amicus Therapeutics reported Interest & Investment Income of $5.4 million as of FY2024, which was down 23.61% from $7.1 million recorded in FY2023.
  • In the past 5 years, Amicus Therapeutics' Interest & Investment Income ranged from a high of $7.1 million in FY2023 and a low of $509,000 during FY2021.
  • Moreover, its 3-year median value for Interest & Investment Income was $5.4 million (2024), whereas its average is $5.2 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first tumbled by 84.22% in 2021, then spiked by 494.11% in 2022.
  • Yearly analysis of 5 years shows Amicus Therapeutics' Interest & Investment Income stood at $3.2 million in 2020, then slumped by 84.22% to $509,000 in 2021, then spiked by 494.11% to $3.0 million in 2022, then surged by 134.06% to $7.1 million in 2023, then fell by 23.61% to $5.4 million in 2024.